Showing results (471-480 of 2,294) with videos related to

Sort By:
Pageof 230
Cancer Research and Treatment|March 24, 2023
Combination of the LARS1 Inhibitor, BC-LI-0186 with a MEK1/2 Inhibitor Enhances the Anti-Tumor Effect in Non-Small Cell Lung CancerSang Hoon Lee, Eun Young Kim, Jung Min Han, et al.
Cancer Research and Treatment|March 6, 2025
The Profile of Gut Microbiota in Carcinogenesis Driven by Mutant EGFR in Non-Small Cell Lung CancerDa-Som Kim, Eun Hye Kim, Ji Yong Kim, et al.
Cancer Research and Treatment|February 25, 2025
Validating the Korean Geriatric Assessment Tool in Elderly Multiple Myeloma Patients: A Multicenter StudyJi Yun Lee, Sang-A Kim, Youngil Koh, et al.
Cancer Research and Treatment|February 25, 2025
Epidermal Growth Factor Receptor Aberrations Identified by Next-generation Sequencing in Patients with Metastatic CancersMinkyue Shin, Dae-Ho Choi, Jaeyun Jung, et al.
Cancer Research and Treatment|February 11, 2025
Preoperative Prediction Model for Early Recurrence of Intrahepatic Cholangiocarcinoma After Surgical Resection: Development and External Validation StudyDong Hwan Kim, Sang Hyun Choi, Sehee Kim, et al.
Cancer Research and Treatment|November 1, 2024
Determinants of Prostate Cancer Screening in Korean Men: A Nationwide Study Using the Korean National Cancer Screening Survey 2023Giap Viet Nguyen, Kyeongmin Lee, Hyeon Ji Lee, et al.
Cancer Research and Treatment|November 1, 2024
Impact of TTF-1 Expression on the Prognostic Prediction of Patients with Non-Small Cell Lung Cancer with PD-L1 Expression Levels of 1% to 49%, Treated with Chemotherapy vs. Chemoimmunotherapy: A Multicenter, Retrospective StudyNaoya Nishioka, Tae Hata, Tadaaki Yamada, et al.
Cancer Research and Treatment|November 1, 2024
Unraveling the Impact of Sarcopenia-Induced Lymphopenia on Treatment Response and Prognosis in Patients with Stage III Non-Small Cell Lung Cancer: Insights for Optimizing Chemoradiation and Immune Checkpoint InhibitorJoongyo Lee, Kyung Hwan Kim, Jina Kim, et al.
Cancer Research and Treatment|November 12, 2024
To Use or Not to Use: Temozolomide in Elderly Patients with IDH Wild-type MGMT Promoter Unmethylated Glioblastoma Treated with RadiotherapyChan Woo Wee, Joo Ho Lee, Hye In Lee, et al.
Cancer Research and Treatment|November 8, 2024
Time-Trend Analysis and Risk Factors for Niraparib-Induced Nausea and Vomiting in Ovarian Cancer: A Prospective StudyYoung Wook Jeong, Dongkyu Eugene Kim, Ji Hyun Kim, et al.
Pageof 230